Clinical Trial Update: Peri-Operative Magnesium Infusion to Prevent Atrial Fibrillation Evaluated. [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 trial evaluating peri-operative magnesium infusion to prevent new-onset atrial fibrillation has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: HagaZiekenhuis | Conditions: Atrial Fibrillation New Onset | Phase 2, Phase 3 | Status: TERMINATED